Hess D C, D'Cruz I A, Adams R J, Nichols F T
Neurology Service, Veterans Affairs Medical Center, Augusta, Georgia.
Neurol Clin. 1993 May;11(2):399-417.
The incidence of in-hospital stroke complicating acute myocardial infarction is approximately 1%. This rate is largely unaffected by thrombolytic therapy. Large myocardial infarctions, anterior wall involvement, prior stroke, and increasing age are risk factors for ischemic stroke. Left ventricular thrombi commonly occur with anterior wall infarctions. There is some evidence that anticoagulation reduces their incidence and uncontrolled studies suggest that anticoagulation may reduce the risk of embolization. Left ventricular aneurysms have a low rate of embolization and do not require systemic anticoagulation. Treatment of acute myocardial infarction with t-PA and anisoylated plasminogen streptokinase activator complex are associated with a higher risk of stroke than treatment with streptokinase; this excess risk is attributable to an increased rate of cerebral hemorrhages.
急性心肌梗死并发院内卒中的发生率约为1%。该发生率在很大程度上不受溶栓治疗的影响。大面积心肌梗死、前壁受累、既往卒中以及年龄增长是缺血性卒中的危险因素。左心室血栓常见于前壁梗死。有证据表明抗凝治疗可降低其发生率,非对照研究提示抗凝治疗可能降低栓塞风险。左心室室壁瘤的栓塞发生率较低,不需要全身抗凝治疗。与链激酶治疗相比,用组织型纤溶酶原激活剂(t-PA)和茴香酰化纤溶酶原链激酶激活剂复合物治疗急性心肌梗死与更高的卒中风险相关;这种额外风险归因于脑出血发生率增加。